Current targeted therapeutics against COVID-19: Based on first-line experience in China

SARS-CoV-2 is a novel strain, causing a global pandemic since the end of 2019. The majority of patients showed nonspecific symptoms such as fever, dry cough, and fatigue. Most patients have a good prognosis while some with severe conditions could rapidly progress to acute respiratory distress syndro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yue, Xu, Qianhao, Sun, Zhuoyan, Zhou, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192075/
https://www.ncbi.nlm.nih.gov/pubmed/32360585
http://dx.doi.org/10.1016/j.phrs.2020.104854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192075/
https://www.ncbi.nlm.nih.gov/pubmed/32360585
http://dx.doi.org/10.1016/j.phrs.2020.104854

Ejemplares similares